DCM Shriram Limited has informed the Exchange about Transcript
DCMSHRIRAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
DCM Shriram reported Q4 FY26 net revenues of INR 3,193 crore (+11% YoY) with PBDIT at INR 400 crore vs INR 426 crore last year. Full-year FY26 revenues stood at INR 13,538 crore (+12%) with PBDIT of INR 1,694 crore (+15%). The company declared a total dividend of 560% (INR 174.66 crore). Key highlights include Chemicals revenue up 32% (PBDIT flat due to expansion costs and one-time INR 19 crore Gujarat incentive), Vinyl PBDIT up 68% on higher prices, while Sugar & Ethanol PBDIT declined 18% due to higher cane costs. Fenesta crossed INR 1,000 crore revenue milestone (INR 1,112 crore, +28%). The newly commissioned ECH plant is running at 60-70% utilization with break-even expected in FY27. Management flagged high commodity price volatility across caustic, PVC and sugar, with PVC facing continued Chinese dumping pressure despite ongoing industry efforts for MIP/ADD protection. Capex guidance for FY27 is INR 1,000-1,200 crore.
The diversified chemical and agrochemical conglomerate delivered revenue growth but margin pressure in chemicals and sugar segments. The newly commissioned ECH plant and epoxy capacity expansion (INR 101 crore to 50 KTPA by Q2 FY28) are key growth drivers. High capex plans (INR 1,000-1,200 crore) signal continued investment phase. Management's cautious tone on commodity pricing and geopolitical uncertainties suggests near-term earnings may remain volatile.